Mouse models of human cancer as tools in drug development

Eric C Holland1

  • 1Memorial Sloan-Kettering Cancer Center, Departments of Surgery (Neurosurgery), Neurology, and Cell Biology and Genetics, 1275 York Avenue, New York, NY 10021, USA. hollande@mskcc.org

Cancer Cell
|September 24, 2004
PubMed

Insights

Mouse cancer models accurately mimic human tumors. Targeting downstream signaling pathways shows promise for effective solid tumor drug development.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Development of histologically accurate mouse cancer models through genetic modification.
  • Recapitulation of human tumor genetic alterations in these models.

Discussion:

  • Testing a novel signaling inhibitor in a genetically defined mouse medulloblastoma model.
  • Demonstration of the utility of genetically engineered mouse models in preclinical drug development.

Key Insights:

  • Targeting signaling components downstream of tumor-initiating mutations is a viable therapeutic strategy.
  • Genetically defined mouse models are crucial for evaluating novel cancer therapies.

Outlook:

  • Potential for advancing drug development pipelines for solid tumors.
  • Future research directions in targeted cancer therapy using mouse models.